Legislative Activity

The EACH Act of 2025 aims to ensure equal access to abortion coverage by requiring all federally funded health programs and facilities to cover abortion services. This legislation prohibits federal interference with state or private insurance coverage of abortion and repeals Section 1303 of the Affordable Care Act. Ultimately, the bill seeks to eliminate financial and insurance barriers to abortion care, particularly for low-income individuals relying on programs like Medicaid.

The Burma Genocide Accountability and Protection Act (Burma GAP Act) establishes a comprehensive U.S. policy to address the ongoing atrocities against the Rohingya people in Myanmar. The bill mandates the appointment of a Special Representative for Burma, increases humanitarian and protection support for refugees, and prioritizes accountability for genocide and crimes against humanity. Furthermore, it commits the U.S. to isolating the military junta until civilian rule is restored.

The Price Gouging Prevention Act of 2025 establishes federal prohibitions against selling goods or services at "grossly excessive prices," particularly following an "exceptional market shock." The bill grants enforcement authority to the Federal Trade Commission (FTC) and allows State Attorneys General to bring actions against violators. Furthermore, it mandates that companies experiencing a market shock must provide detailed financial and pricing strategy disclosures in subsequent SEC filings.

The NOPAIN for Veterans Act mandates that the Department of Veterans Affairs (VA) must promptly add specific, FDA-approved non-opioid pain medications to its National Formulary. This ensures veterans have access to alternative pain management options that do not rely on opioids. The VA is required to implement these changes within 90 days of the Act becoming law.

The Cosmetic Hazardous Ingredient Right to Know Act of 2025 significantly updates cosmetic regulation by mandating comprehensive ingredient disclosure, especially for fragrances and flavors, on both product labels and brand owner websites. This law requires detailed, machine-readable online ingredient lists and specific hazard warnings on packaging if certain harmful chemicals are present. Importantly, this federal act preserves the authority of states to enact stricter ingredient bans or transparency requirements.

The Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025 mandates that employers protect workers from dangerous heat stress by establishing comprehensive safety standards. This Act requires the Secretary of Labor to create evidence-based rules covering engineering controls, administrative procedures, required training, and paid rest breaks to prevent heat-related illness. Furthermore, the law establishes strict enforcement mechanisms, whistleblower protections, and specific timelines for the implementation of these new federal heat protection standards.

This resolution declares a health and safety emergency disproportionately affecting children due to prior administration directives that promoted fossil fuels and suppressed climate science. Congress asserts that these actions harm children's fundamental rights to life and a stable environment by worsening climate change impacts. The bill demands the current administration cease policies that increase greenhouse gases and restore access to suppressed climate research. Ultimately, it calls for aligning all energy and climate laws with the duty to protect the rights and future of young people.

The Stop ICE from Kidnapping U.S. Citizens Act strictly prohibits U.S. Immigration and Customs Enforcement (ICE) from using any federal funds for civil immigration enforcement activities involving U.S. citizens. Specifically, this bill bans ICE from spending money to detain or transport any citizen of the United States. This measure ensures federal funds are not used to wrongfully target or remove American citizens.

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

The Toxic-Free Beauty Act of 2025 establishes new federal standards for cosmetic safety by banning the intentional addition of specific harmful chemicals, such as formaldehyde and certain parabens, in products sold in the U.S. It also sets maximum allowable limits for certain contaminants like 1,4 dioxane and lead. Importantly, this federal legislation does not preempt stricter state laws regarding cosmetic ingredients. These new requirements will take effect for products shipped interstate starting January 1, 2027.

The Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025 aims to enhance cosmetic safety through targeted research into health disparities affecting communities of color and salon workers. The bill mandates improved access to safety data sheets in multiple languages for professional products and establishes two new National Resource Centers to empower these communities and workers. Finally, it brings synthetic hair braids under FDA cosmetic regulation, requiring new safety standards and labeling.

This bill, titled the Epstein Files Transparency Act, mandates the Attorney General to release nearly all unclassified Department of Justice records related to Jeffrey Epstein within 30 days of enactment. The legislation strictly limits the justifications for withholding or redacting documents, prohibiting secrecy based on political sensitivity or potential embarrassment. The only permissible redactions involve victim privacy, child sexual abuse material, or narrowly defined threats to active investigations or national security classifications. Upon completion, the Attorney General must submit a detailed report to Congress listing all released and withheld materials, including an unredacted list of all named government officials.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

The Safeguarding Transit Operations to Prohibit China Act (STOP China Act) bans the use of federal transit funds to purchase or maintain transit vehicles and related infrastructure connected to specified foreign entities, primarily those linked to China. This prohibition targets "covered vehicles" supplied by "covered entities" to prevent national security risks and unfair trade practices. The law mandates the creation of a public watchlist identifying these restricted entities to ensure compliance.

The Pharmacy Benefit Manager Reform Act of 2025 aims to increase transparency and accountability across the prescription drug supply chain. It mandates fairer pharmacy network access for Medicare beneficiaries and imposes strict new financial reporting and service fee requirements on Pharmacy Benefit Managers (PBMs) working with Medicare and private health plans. Furthermore, the bill establishes new federal mechanisms to accurately track drug acquisition costs in Medicaid and explicitly bans the practice of "spread pricing" in state Medicaid contracts.

The Food Chemical Reassessment Act of 2025 mandates that the FDA systematically review the safety of at least ten existing food ingredients every three years, starting in 2026. This process targets substances like certain food additives, colorings, and GRAS ingredients, prioritizing those with the greatest public health concern. If a reassessment determines a substance is unsafe, the FDA is required to take regulatory action, such as repealing approvals or revoking authorizations. The Act also establishes an advisory committee to guide the FDA on reassessment standards and methods.

This resolution expresses support for designating July 10th as Journeyman Lineworkers Recognition Day. It honors the essential and dangerous work performed by these skilled professionals, especially their heroic efforts in restoring power after major disasters. The day serves to recognize their service and remember those who have lost their lives performing this vital work.

The FAIR Bet Act amends tax law to allow taxpayers to deduct wagering losses dollar-for-dollar against their wagering winnings, up to 100% of those winnings. This change modifies the previous limitation on deducting gambling losses. Essentially, it ensures that gambling losses can fully offset gambling income for tax purposes.